FRANKFURT: BioNTech’s co-founder and chief government stated he was optimistic that the protecting impact of its experimental COVID-19 vaccine, co-developed with Pfizer, would final for at the very least a yr.
The 2 firms earlier on Monday turned the primary drugmakers to launch profitable trial information, saying their vaccine was proven to be greater than 90% efficient, a significant victory within the struggle towards the pandemic.
“We needs to be extra optimistic that the immunisation impact can final for at the very least a yr,” CEO Ugur Sahin instructed Reuters.
Whereas it was not but recognized how lengthy the safety would final, analysis on recovered sufferers and earlier findings on their vaccine led him to imagine safety wouldn’t be short-lived.
Disclaimer: This publish has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor